by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Bentley Laboratories LLC Warning Letter Details

Warning Letter

Bentley Laboratories LLC

111 Fieldcrest Avenue Edison , NJ 08837-3622 United States

Issue DateSeptember 17, 2026

FEI Number2244819

Violations5

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated

Bentley Laboratories LLC FDA Warning Letter, September 17, 2026